NCT05069766View on ClinicalTrials.gov

Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Esophagus Cancer, Adenocarcinoma
Interventions
OTHER

BioXmark™

During a scheduled outpatient gastroscopy, the tumor margins will be endoscopically marked by BioXmark™. BioXmark™ will be implanted at the most proximal margin of the tumor and 5 cm proximally of the tumor border.

Trial Locations (1)

2100

Rigshopitalet, Department of Surgery and Transplantation, Copenhagen

Sponsors

Collaborators (1)

Nanovi
All Listed Sponsors
collaborator

Nanovi

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT05069766 - Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences | Biotech Hunter | Biotech Hunter